MARK P COLONNESE Insider Trading
Get free email notifications about insider trading for MARK P COLONNESE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK P COLONNESE. MARK P COLONNESE is a CFO and EVP in Aviragen Therapeutics, Inc. ($NABI) and a Chief Financial Officer in Aviragen Therapeutics, Inc. ($NABI) and a Exec VP Comm Operations & CFO in ATHEROGENICS INC ($AGIX) and a Exec VP Commercial Operations in ATHEROGENICS INC ($AGIX) and a Exec VP, Commercial Operations in ATHEROGENICS INC ($AGIX) and a Sr VP Finance & Admin & CFO in ATHEROGENICS INC ($AGIX) and a Sr VP Finance & Admin, CFO in ATHEROGENICS INC ($AGIX) and a Sr VP Finance, Admin & CFO in ATHEROGENICS INC ($AGIX) and a Sr VP Finance/Admin & CFO in ATHEROGENICS INC ($AGIX) and a Sr VP, Finance & Admin, CFO in ATHEROGENICS INC ($AGIX) and a Director in BIO-PATH HOLDINGS INC ($BPTH).
Address: 8995 WESTSIDE PARKWAY ALPHARETTA 30004 GA
Companies in which MARK P COLONNESE is an Insider
ATHEROGENICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK P COLONNESE: Exec VP Comm Operations & CFO, Exec VP Commercial Operations, Exec VP, Commercial Operations, Sr VP Finance, Admin & CFO, Sr VP Finance & Admin & CFO, Sr VP Finance/Admin & CFO, Sr VP Finance & Admin, CFO, Sr VP, Finance & Admin, CFO
Holdings: 25,000 shares
Latest Transaction: Jan 14 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIO-PATH HOLDINGS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK P COLONNESE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 01 2019
$BPTH Market Capitalization: $81.31M
$BPTH Previous Close: $0.86
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vaxart, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MARK P COLONNESE: CFO and EVP, Chief Financial Officer
Holdings: 7,000 shares
Current Value: $7,980
Latest Transaction: Apr 05 2017
$VXRT Market Capitalization: $43.28M
$VXRT Previous Close: $1.14
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MARK P COLONNESE
Sentiment: All, AGIX, BPTH, VXRT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2019 | BPTH | BIO-PATH HOLDINGS ... | COLONNESE MARK P | Director | Option Exercise | A | 18.40 | 1,000 | 18,400 | 1,000 | |
| Apr 01 2019 | BPTH | BIO-PATH HOLDINGS ... | COLONNESE MARK P | Director | Option Exercise | A | 18.40 | 1,000 | 18,400 | 1,000 | |
| Apr 19 2018 | BPTH | BIO-PATH HOLDINGS ... | COLONNESE MARK P | Director | Option Exercise | A | 1.68 | 20,000 | 33,500 | 20,000 | |
| Jul 17 2017 | BPTH | BIO-PATH HOLDINGS ... | COLONNESE MARK P | Director | Option Exercise | A | 0.38 | 25,000 | 9,500 | 25,000 | |
| Apr 05 2017 | AVIR | Aviragen Therapeut ... | COLONNESE MARK P | Chief Financial Off ... | Option Exercise | A | 0.66 | 400,000 | 262,400 | 775,000 | |
| Jul 29 2016 | NABI | Aviragen Therapeut ... | COLONNESE MARK P | CFO and EVP | Option Exercise | A | 1.34 | 150,000 | 201,000 | 375,000 | |
| Feb 09 2016 | NABI | Aviragen Therapeut ... | COLONNESE MARK P | Chief Financial Off ... | Buy | P | 1.41 | 6,700 | 9,428 | 7,000 | 300 to 7 K (+2,233.33 %) |